Browse 24950 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 15th, 2023 |
Specialized Alcohol Research Centers (P50 Clinical trial Optional) |
National Institutes of Health |
| October 3rd, 2023 |
Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 3rd, 2023 |
Accelerating Behavioral and Social Science through Ontology Development and Use: Dissemination and Coordination Center (U24) Clinical Trial Not Allowed |
National Institutes of Health |
| August 4th, 2023 |
NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional) |
National Institutes of Health |
| November 10th, 2023 |
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
| November 9th, 2023 |
Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
| August 17th, 2023 |
Limited Competition for the NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 4th, 2023 |
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| October 4th, 2023 |
Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| November 30th, 2023 |
Rape Prevention and Education |
Centers for Disease Control NCIPC |
| July 24th, 2023 |
Service Area Competition |
Health Resources and Services Administration |
| August 15th, 2023 |
Health Equity Data Access Program (HEDAP) |
Centers for Medicare Medicaid Services |
| July 28th, 2023 |
Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| June 16th, 2023 |
Health Information Systems (HIS) Activity |
Haiti USAID Port Au Prince |
| July 11th, 2023 |
USAID Controlling HIV/AIDS Epidemic among Key and Vulnerable Populations (CHEK) through Local Partnership |
Democratic Republic of the Congo USAID Kinshasa |
| July 11th, 2023 |
USAID Combating HIV/AIDS Through Local Partnership Activity (CHALPA)-Lualaba |
Democratic Republic of the Congo USAID Kinshasa |
| July 11th, 2023 |
Family Counseling and Support for Lesbian, Gay, Bisexual, Transgender, Queer/Questioning, Intersex+ Youth and their Families |
Substance Abuse and Mental Health Services Adminis |
| July 11th, 2023 |
USAID Combating HIV/AIDS Through Local Partnership Activity (CHALPA)-Kinshasa |
Democratic Republic of the Congo USAID Kinshasa |
| April 3rd, 2026 |
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 7th, 2023 |
Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| October 23rd, 2023 |
Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)? |
National Institutes of Health |
| October 23rd, 2023 |
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)? |
National Institutes of Health |
| February 26th, 2026 |
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 26th, 2023 |
Tamkeen (an Arabic word meaning Empowerment) |
South Sudan (USAID) Juba |
| October 26th, 2023 |
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 26th, 2023 |
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 23rd, 2023 |
Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 23rd, 2023 |
Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 23rd, 2023 |
Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 2nd, 2023 |
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) |
National Institutes of Health |
| November 2nd, 2023 |
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 2nd, 2023 |
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| August 25th, 2023 |
Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| August 9th, 2023 |
Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed) |
National Institutes of Health |
| July 18th, 2023 |
Support for 988 Tribal Response Cooperative Agreements |
Substance Abuse and Mental Health Services Adminis |
| October 11th, 2023 |
Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 8th, 2024 |
Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) |
National Institutes of Health |
| September 8th, 2023 |
Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| July 18th, 2023 |
Alcohol Treatment and Recovery Research (R34 Clinical Trial required) |
National Institutes of Health |
| July 18th, 2023 |
Alcohol Health Services Research (R34 Clinical Trial Optional) |
National Institutes of Health |
